Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Heart transplantation is advocated in selected patients with advanced heart failure in the
absence of contraindications. Principal challenges in heart transplantation centre around an …

Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from patients …

Background. The clinical effectiveness of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet …

Many safe and effective severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
vaccinations dramatically reduce risks of coronavirus disease 2019 (COVID‐19) …

In response to the COVID‐19 pandemic, SARS‐CoV‐2 vaccines have been developed at an
unparalleled speed, with 14 SARS‐CoV‐2 vaccines currently authorized. Solid‐organ …

Clinical outcomes in solid organ transplant (SOT) recipients with breakthrough COVID
(BTCo) after two doses of mRNA vaccination compared to the non-immunocompromised …

Background Solid organ transplant (SOT) recipients are at increased risk for morbidity and
mortality from COVID-19 due to their immunosuppressed state and reduced immunogenicity …

Introduction Studies have shown reduced antiviral responses in kidney transplant recipients
(KTRs) following SARS-CoV-2 mRNA vaccination, but data on post-vaccination alloimmune …